← Open Payments lookup

NPI 1639360936: Open Payments

NPI 1639360936. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$239 in 11 payments from 5 companies in 2025. Trend: 2023 $1,044 · 2024 $210 · 2025 $239

Food & beverage: $239
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.4$92
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$76
Janssen Pharmaceuticals, Inc2$37
Otsuka America Pharmaceutical, Inc.1$18
Neurocrine BioSciences, Inc.1$17

Products named: AUSTEDO XR, CAPLYTA, SPRAVATO, REXULTI, INGREZZA.